ClinConnect ClinConnect Logo
Search / Trial NCT05389241

Laparoscopic Augmented Reality for Identification of Liver Lesions - a Pre-clinical Randomized Cross-over Trial

Launched by UNIVERSITÄTSKLINIKUM KÖLN · May 19, 2022

Trial Information

Current as of May 22, 2025

Unknown status

Keywords

Augmented Reality Liver Minimally Invasive Surgery Laparoscopy 3 D Spatial Orientation Digital Health Artificial Intelligence

ClinConnect Summary

Procedure preparation and accurate knowledge of the specific anatomy is an integral part of performing a minimally invasive procedure. Due to the complexity with high variability and the non-visibility of the vascular structures due to the location in the parenchyma, the liver poses a particular challenge. The spatial perception and cognitive processing of the anatomical target structures is of particular importance.

The aim of this study is to test the hypothesis that the use of a 3-dimensional (3D) virtual liver model (virtual 3D model crating augmented reality) presenedt on teh laparosc...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • medical student of University of Cologne OR medical doctor in a surgical specialty
  • informed consent signed
  • Exclusion Criteria:
  • known and not correctable deficit of stereoscopic view
  • for medical students: experience with laparoscopy or laparoscopy simulators

About Universitätsklinikum Köln

Universitätsklinikum Köln, located in Cologne, Germany, is a leading academic medical center renowned for its commitment to innovative research, high-quality patient care, and comprehensive medical education. As a prominent sponsor of clinical trials, the institution leverages its multidisciplinary expertise and state-of-the-art facilities to advance the understanding of various diseases and develop novel therapeutic approaches. With a focus on translational research, Universitätsklinikum Köln collaborates with national and international partners to enhance clinical outcomes and contribute to the global medical community.

Locations

Cologne, , Germany

Patients applied

0 patients applied

Trial Officials

Roger Wahba, MD, PHD

Principal Investigator

Universitätsklinikum Köln

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials